Literature DB >> 33479436

Association between triglyceride glucose index and peak growth hormone in children with short stature.

Qianqian Zhao1,2,3, Yuntian Chu4, Hui Pan5,3, Mei Zhang6,7, Bo Ban8,9.   

Abstract

Growth hormone (GH) secretion is related to many factors, such as weight and puberty, and the reproducibility of GH provocation tests is very poor. This study aimed to evaluate whether the triglyceride (TyG) index was associated with peak GH in children with short stature. This study included 1095 children with short stature divided into two groups based on peak GH level in GH provocation tests [GH deficiency (GHD) group = 733 children; non-GHD group = 362 children]. We found that the TyG index was significantly higher in the GHD group than in the non-GHD group (P < 0.001). A nonlinear relationship was detected between the TyG index and peak GH, whose point was 7.8. A significant negative association between the TyG index and peak GH was observed when the TyG index was greater than 7.8 (β - 2.61, 95% CI - 3.98, - 1.24; P < 0.001), whereas, the relationship between the TyG index and peak GH was not significant when the TyG index was lower than 7.8 (β 0.25, 95% CI - 1.68, 2.17; P = 0.799). There is a nonlinear relationship between the TyG index and peak GH, and a higher TyG index is associated with decreased peak GH in children with short stature.

Entities:  

Year:  2021        PMID: 33479436      PMCID: PMC7820337          DOI: 10.1038/s41598-021-81564-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

1.  Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.

Authors:  Johan Svensson; Jesper Fowelin; Kerstin Landin; Bengt-Ake Bengtsson; Jan-Ove Johansson
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

2.  Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.

Authors:  M Christopher; F L Hew; M Oakley; C Rantzau; F Alford
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

Review 3.  Growth Hormone Deficiency in Prepubertal Children: Predictive Markers of Cardiovascular Disease.

Authors:  Chiara De Leonibus; Stefania De Marco; Adam Stevens; Peter Clayton; Francesco Chiarelli; Angelika Mohn
Journal:  Horm Res Paediatr       Date:  2016-03-10       Impact factor: 2.852

4.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Authors:  Miriam A Bredella; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Danielle J Brick; Anu V Gerweck; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

5.  Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.

Authors:  Madhusmita Misra; Miriam A Bredella; Patrika Tsai; Nara Mendes; Karen K Miller; Anne Klibanski
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-10       Impact factor: 4.310

6.  Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

Authors:  Patrick Maison; Simon Griffin; Marc Nicoue-Beglah; Nabila Haddad; Beverley Balkau; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

7.  Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study.

Authors:  Ellen E Blaak; Ilja C W Arts; Nicole Vogelzangs; Carla J H van der Kallen; Marleen M J van Greevenbroek; Birgitta W van der Kolk; Johan W E Jocken; Gijs H Goossens; Nicolaas C Schaper; Ronald M A Henry; Simone J P M Eussen; Armand Valsesia; Thomas Hankemeier; Arne Astrup; Wim H M Saris; Coen D A Stehouwer
Journal:  Int J Obes (Lond)       Date:  2020-03-17       Impact factor: 5.095

8.  Influence of body mass index on the growth hormone response to provocative testing in short children without growth hormone deficiency.

Authors:  Jieun Lee; Juyoung Yoon; Min Jae Kang; Young Ah Lee; Seong Yong Lee; Choong Ho Shin; Sei Won Yang
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

9.  Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.

Authors:  Shuang Liang; Jiang Xue; Guimei Li
Journal:  Lipids Health Dis       Date:  2018-04-03       Impact factor: 3.876

10.  Omarigliptin decreases inflammation and insulin resistance in a pleiotropic manner in patients with type 2 diabetes.

Authors:  Sachiko Hattori
Journal:  Diabetol Metab Syndr       Date:  2020-03-24       Impact factor: 3.320

View more
  2 in total

1.  Serum Metabonomics Reveals Key Metabolites in Different Types of Childhood Short Stature.

Authors:  Guoyou Chen; Jinming Wang; Yisi Jing; Chunxiang Li; Wenyue Zhang; Shuang Yang; Ye Song; Xin Wang; Jincheng Liu; Dejun Yu; Zhichun Xu
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

2.  Association Between the Growth Hormone/Insulin-Like Growth Factor-1 Axis and Muscle Density in Children and Adolescents of Short Stature.

Authors:  Guangzhi Yang; Qing Yang; Yanying Li; Yanhong Zhang; Shuxiong Chen; Dongye He; Mei Zhang; Bo Ban; Fupeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-14       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.